Press | Mayo Clinic Business Development

Latest news

Xsensio announces know-how and stock purchase agreement with Mayo Clinic

PR Web | February 2, 2023

TripleBlind collaborates with Mayo Clinic Platform to de-identify patient data, strengthen privacy, and improve global health care outcomes

Global Newswire | January 31, 2023

Company backed by Mayo, Kaiser debuts ER-at-home program

Becker’s Healthcare | January 12, 2023

EXCERPT: Mayo Clinic and Kaiser Permanente were part of a $110 million funding round for Medically Home in January 2022 after becoming joint strategic investors the previous May.

Mayo Clinic Laboratories and Helix collaborate to provide comprehensive suite of laboratory services to biopharma customers

Mayo Clinic Laboratories | January 10, 2023

French ambassador visits Mayo Clinic and discusses the value of collaboration

Post Bulletin | January 6, 2023

EXCERPT: Mayo Clinic Chief Business Development Officer Jim Rogers spoke to highlight Mayo Clinic’s innovation, citing the launch or involvement with 32 startup companies in 2022 as well as that Mayo inventors have been issued 232 patents.

The Check Up podcast: 15 minutes with Andy Danielsen, Chair of Mayo Clinic Ventures

Modern Healthcare | January 3, 2023

First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

Fierce Biotech | January 3, 2023

MediView enters into know-how agreement with Mayo Clinic to advance clinical extended reality solutions

PR Newswire | December 19, 2022

Pfizer links up with heart disease AI developer Anumana to build cardiac amyloidosis diagnostics

Fierce Biotech | December 16, 2022

EXCERPT: Originally launched in 2021 as a joint venture between nference and the Mayo Clinic, Anumana will now work with Pfizer on a multiyear research project.

‘For the Record’ with Jim Rogers, Chief Business Development Officer of Mayo Clinic

Medical Alley Association | December 2022

Girihlet announces know-how agreement with Mayo Clinic

PR Newswire | December 13, 2022

Ultromics receives FDA clearance for its breakthrough device EchoGo Heart Failure: An AI-based platform that enables precision detection of heart failure with preserved ejection fraction

PR Newswire | December 6, 2022

Endoluxe announces know-how agreement with Mayo Clinic

Business Wire | December 5, 2022

Blog: Mayo Clinic Business Development: Harnessing innovation, collaboration and business strategy to advance patient care

Medical Alley Association | December 2022

Shift Forward Health: Jim Rogers of Mayo Clinic

Healthcare Changemakers Podcast | November 30, 2022

Mayo Clinic Q&A: An inside look at invention at Mayo Clinic

Mayo Clinic News Network | November 29, 2022

Additional Sources: YouTube, Apple Podcasts, Spotify

Atropos Health and Mayo Clinic collaborate to bring real-world evidence to patient bedside

PR Newswire | November 11, 2022

Mayo Clinic spinout Anumana acquires NeuTrace to develop cardiac procedure AI

Fierce Biotech | November 8, 2022

MGFB announces agreement with Mayo Clinic for development of novel therapeutic cancer vaccines

PR Newswire | November 8, 2022

New Mayo Clinic journal promises to be part of ‘disruptive transformation’ in medicine

Post Bulletin | October 20, 2022

EXCERPT: “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.

Mayo Clinic is No. 1 research institution for technology transfer, new ranking shows

Biz Journals | October 20, 2022

Mayo Clinic-backed CDMO Nucleus RadioPharma emerges on a mission to overhaul radiotherapy access

FiercePharma | October 25, 2022

Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients

Mayo Clinic News Network | October 12, 2022

Navigating the ‘perilous path’ of healthcare innovation

Healthcare IT News | October 3, 2022

nference launches real-world data platform, expands Mayo Clinic partnership

MobiHealthNews | September 21, 2022

Moat Biotechnology forms to develop novel mucosal vaccines for COVID-19 and beyond

BioSpace | September 20, 2022

EXCERPT: MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19.

Mayo Clinic, Hibiscus BioVentures and Innoforce announce Mayflower cell and gene therapy accelerator

Mayo Clinic News Network | August 31, 2022

Castle Creek Biosciences announces publication of preclinical study for potential in vivo gene therapy in Nature Communications

PR Newswire | August 30, 2022

Genomadix Inc. announces know-how license agreement with Mayo Clinic

PR Newswire | August 29, 2022

National Resilience, hot off $625M raise, bolsters Rolodex with Mayo Clinic biomanufacturing tie-up

Fierce Pharma | August 18, 2022

Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing

Mayo Clinic News Network | August 15, 2022

Diagnostic Robotics raises $45M Series B

Mass Device | August 1, 2022

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Light Line Medical enters into know-how license agreement with Mayo Clinic

Business Wire | July 20, 2022

Lisa Health launches Midday, an app leveraging AI to personalize the menopause journey, in collaboration with Mayo Clinic

Mayo Clinic News Network | July 19, 2022

Novartis turns to algorithms developer Anumana to apply AI to cardio conditions

Med City News | July 15, 2022

EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI

Fierce Biotech | July 14, 2022

VeriSIM Life enters into collaboration agreement with Mayo Clinic to jointly advance drug discovery and development programs

Business Wire | June 28, 2022

Mayo Clinic, Médica Sur expand relationship to advance cancer care

Mayo Clinic News Network | June 21, 2022

Mayo Clinic, K Health team up to use AI for personalized hypertension treatment

Fierce Healthcare | June 20, 2022

Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension

Mass Devices | May 24, 2022

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.

Mayo Clinic buys minority stake in Karkinos Healthcare

Mayo Clinic News Network | May 23, 2022

Rochester startup Vyriad developing cancer-fighting viruses

Star Tribune | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer

Vyriad, Inc. raises $29.5M in Series B funding led by renowned genetics entrepreneur

PR Newswire | May 17, 2022

Mayo Clinic researchers use AI to detect weak heart pump via patients’ Apple Watch ECGs

Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

KLOC Health enters into know-how agreement with Mayo Clinic for health staffing platform

PR Newswire | April 14, 2022

Pramana launches digital pathology as a service platform, offering comprehensive and scalable glass slide digitization for health systems

Business Wire | March 16, 2022

EXCERPT: Pramana’s first commercial agreement with Mayo Clinic is a multi-year collaboration that includes an industry-leading initiative to digitize 5 million slides – one of the largest digitization efforts in the world to date, at an unprecedented rate.

OpenDNA announces know-how and research agreement with Mayo Clinic as part of pilot clinical study for cardiovascular disease prevention

Medgadget | March 9, 2022

St. Jude founder and Minnesota med tech trailblazer is driven by heart

Star Tribune | February 7, 2022

EXCERPT: The company [Medical21] is collaborating with Mayo Clinic, which owns an equity stake in the company. Juan Crestanello, a cardiovascular surgeon at Mayo, said he and his colleagues have seen some of Medical 21’s work. “The results, so far, have been very encouraging,” Crestanello said.

Pathogenomix granted FDA Breakthrough Device Designation

PR Newswire | January 19, 2022

EXCERPT: Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation.

Baxter, Cardinal Health join Mayo Clinic, Kaiser with $110 million stake in ‘hospital care at home’ venture

Forbes | January 10, 2022

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

PR Newswire | January 6, 2022

NaNotics to collaborate with Mayo Clinic on nanomedicine cancer treatment

Business Wire | January 4, 2022

Mesuron Inc. announces know-how license agreement and stock purchase agreement with Mayo Clinic

Globe Newswire | January 4, 2022

Two Discovery Square to open for next wave of biotech collaboration with Mayo Clinic

Star Tribune | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic.